Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oxyeye is an oral nutraceutical supplement developed and marketed by Eyekare Kilitch, the ophthalmic division of Kilitch Healthcare. It is formulated to support eye health, vision, and general wellness by combating oxidative stress. The supplement is available in different formulations, including Oxyeye Tablet, which contains astaxanthin, lutein, and essential vitamins and minerals, and Oxyeye Capsule, which contains beta-carotene, copper sulphate, L-glutathione, lutein, manganese chloride, selenious acid, and zinc oxide. These ingredients act as potent antioxidants that protect ocular tissues from free radical damage and environmental stressors like sunlight.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Oxyeye.